dNTP Mix (2.5 mM)

Invitrogen 2.5 mM dNTP (2'-deoxynucleoside 5'-triphosphate) Mix consists of a solution of all four nucleotides, dATP, dCTP, dGTP, and dTTP,Read more

Catalog Number	Quantity
R72501	1 mL

Catalog number R72501

Price (MXN)

Quantity:

Request bulk or custom format

Invitrogen 2.5 mM dNTP (2'-deoxynucleoside 5'-triphosphate) Mix consists of a solution of all four nucleotides, dATP, dCTP, dGTP, and dTTP, each at a concentration of 2.5 mM. It is supplied in purified water and neutralized to pH 8.0 with NaOH. 2.5 mM dNTP Mix is suitable for use in a wide variety of molecular applications.

Applications
• Traditional PCR
• Sequencing
• cDNA synthesis
• Nick translation
• TdT-tailing reactions

For Research Use Only. Not for use in diagnostic procedures.

Specifications

Quantity1 mL

Shipping ConditionDry Ice

Concentration2.5 mM

For Use With (Application)Standard PCR

FormLiquid

Label or DyeUnlabeled

Unit SizeEach

Contents & Storage

dNTP Mix, 2.5 mM (2 x 500 μL)

Store at –20°C.

Citations & References (1)

Citations & References

Abstract

Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemia.

Authors: Blanco J G; Dervieux T; Edick M J; Mehta P K; Rubnitz J E; Shurtleff S; Raimondi S C; Behm F G; Pui C H; Relling M V;

Journal:Proc Natl Acad Sci U S A

PubMed ID:11526240

Therapy-related acute myeloid leukemias (t-AML) with translocations of the MLL gene are associated with the use of topoisomerase II inhibitors. We established the emergence of the malignant clone in a child who developed t-AML with a t(11;19) (q23;p13.3) during treatment for acute lymphoblastic leukemia (ALL). The MLL-ENL and the reciprocal ... More